Myeloid-Derived Suppressor Cells Regulate Immune Response in Patients with Chronic Hepatitis B Virus Infection through PD-1–Induced IL-10

Journal of Immunology - Tập 193 Số 11 - Trang 5461-5469 - 2014
Ang Huang1,2, Bo Zhang3, Weiwei Yan2, Bo Wang1, Huafeng Wei3, Fan Zhang1, Lang Wu4, Kexing Fan1,3, Yajun Guo1,3
1*Cancer Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, People’s Republic of China;
2†Department of Liver Diseases, Beijing 302 Hospital, Beijing 100039, People’s Republic of China;
3‡International Joint Cancer Institute, Second Military Medical University, Shanghai 200433, People’s Republic of China; and
4§Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN 55905

Tóm tắt

Abstract Although myeloid-derived suppressor cells (MDSCs) are well known for their immunosuppressive function in several pathological conditions, the role of MDSCs in hepatitis B virus infection remains obscure. In this study, we investigated the frequency and function of MDSCs in the peripheral blood and liver of 91 chronic hepatitis B (CHB) patients. A higher percentage of MDSCs, defined as CD14+HLA-DR−/low, was detected in peripheral blood of CHB patients than that of the healthy controls. Moreover, high expression of programmed death 1 (PD-1) and secretion of IL-10 in this population were determined. The frequency of MDSCs was positively correlated with serum viral load, but it was negatively correlated with liver inflammatory injury. These cells were also abundant in liver tissue of CHB patients and were related to necroinflammatory activity. Furthermore, we found that these cells could suppress hepatitis B virus–specific CD8+ T cell response, including reduced proliferation and IFN-γ production, and inhibit degranulation of CD8+ T cells, including reduced production of granzyme B and perforin. Importantly, PD-1–induced IL-10 production by MDSCs was responsible for the suppressive activity. To our knowledge, for the first time our study proved that CD14+HLA-DR–/lowPD-1+ MDSCs in CHB patients contribute to an inadequate immune response against the virus and lead to chronic infection, which represents a potential target for therapeutic intervention.

Từ khóa


Tài liệu tham khảo

Rehermann, 2005, Immunology of hepatitis B virus and hepatitis C virus infection., Nat. Rev. Immunol., 5, 215, 10.1038/nri1573

Wang, 2009, Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus., Expert Rev. Gastroenterol. Hepatol., 3, 499, 10.1586/egh.09.50

Bertoletti, 2012, Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection., Gut, 61, 1754, 10.1136/gutjnl-2011-301073

Schurich, 2011, Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection., Hepatology, 53, 1494, 10.1002/hep.24249

Youn, 2008, Subsets of myeloid-derived suppressor cells in tumor-bearing mice., J. Immunol., 181, 5791, 10.4049/jimmunol.181.8.5791

Lin, 2011, Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma., Blood, 117, 872, 10.1182/blood-2010-05-283820

Huang, 2013, Increased CD14+HLA-DR−/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients., Cancer Immunol. Immunother., 62, 1439, 10.1007/s00262-013-1450-6

Chikamatsu, 2012, Immunosuppressive activity of CD14+ HLA-DR− cells in squamous cell carcinoma of the head and neck., Cancer Sci., 103, 976, 10.1111/j.1349-7006.2012.02248.x

Hoechst, 2008, A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells., Gastroenterology, 135, 234, 10.1053/j.gastro.2008.03.020

Filipazzi, 2007, Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine., J. Clin. Oncol., 25, 2546, 10.1200/JCO.2006.08.5829

Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system., Nat. Rev. Immunol., 9, 162, 10.1038/nri2506

Mirza, 2006, All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients., Cancer Res., 66, 9299, 10.1158/0008-5472.CAN-06-1690

Walter, 2012, Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival., Nat. Med., 18, 1254, 10.1038/nm.2883

Vasquez-Dunddel, 2013, STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients., J. Clin. Invest., 123, 1580, 10.1172/JCI60083

Jitschin, 2014, CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs., Blood, 124, 750, 10.1182/blood-2013-12-546416

Haile, 2008, Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway., Gastroenterology, 871

Vollbrecht, 2012, Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells., AIDS, 26, F31, 10.1097/QAD.0b013e328354b43f

Zeng, 2014, Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8+ T cells in chronic hepatitis C patients., Mol. Cells, 37, 66, 10.14348/molcells.2014.2282

Cai, 2013, Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients., J. Clin. Immunol., 33, 798, 10.1007/s10875-012-9861-2

Tacke, 2012, Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species., Hepatology, 55, 343, 10.1002/hep.24700

Qin, 2013, Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals., J. Virol., 87, 1477, 10.1128/JVI.01759-12

Garg, 2014, HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity., J. Infect. Dis., 209, 441, 10.1093/infdis/jit469

European Association for the Study of the Liver, 2012, EASL clinical practice guidelines: Management of chronic hepatitis B virus infection., J. Hepatol., 57, 167, 10.1016/j.jhep.2012.02.010

Scheuer, 1991, Classification of chronic viral hepatitis: a need for reassessment., J. Hepatol., 13, 372, 10.1016/0168-8278(91)90084-O

Yang, 2010, Immune effectors required for hepatitis B virus clearance., Proc. Natl. Acad. Sci. USA, 107, 798, 10.1073/pnas.0913498107

Zhang, 2011, Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B., PLoS ONE, 6, e17484, 10.1371/journal.pone.0017484

Vuk-Pavlović, 2010, Immunosuppressive CD14+HLA-DRlow/− monocytes in prostate cancer., Prostate, 70, 443, 10.1002/pros.21078

Fu, 2007, Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients., Gastroenterology, 132, 2328, 10.1053/j.gastro.2007.03.102

Poschke, 2010, Immature immunosuppressive CD14+HLA-DR−/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign., Cancer Res., 70, 4335, 10.1158/0008-5472.CAN-09-3767

Zou, 2009, Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-α, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection., J. Clin. Gastroenterol., 43, 182, 10.1097/MCG.0b013e3181624464

Brunetto, 2009, Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B., Hepatology, 49, 1141, 10.1002/hep.22760

Nagaraj, 2010, Myeloid-derived suppressor cells in human cancer., Cancer J., 16, 348, 10.1097/PPO.0b013e3181eb3358

Nonnenmann, 2014, Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals., J. Virol., 88, 7678, 10.1128/JVI.00113-14

Chen, 2011, Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus., Clin. Exp. Immunol., 166, 134, 10.1111/j.1365-2249.2011.04445.x

Klenerman, 2005, T cells and viral persistence: lessons from diverse infections., Nat. Immunol., 6, 873, 10.1038/ni1241

Buti, 2001, Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B., J. Infect. Dis., 183, 1277, 10.1086/319677

Castells, 2002, Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation., Liver Transpl., 8, 892, 10.1053/jlts.2002.35555

Feng, 2012, CD14+S100A9+ monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer., Am. J. Respir. Crit. Care Med., 186, 1025, 10.1164/rccm.201204-0636OC

Saito, 2008, Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production., J. Virol., 82, 3320, 10.1128/JVI.02547-07

Hart, 2011, IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer., Front. Immunol., 2, 29, 10.3389/fimmu.2011.00029

Lechner, 2010, Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells., J. Immunol., 185, 2273, 10.4049/jimmunol.1000901

Said, 2010, Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection., Nat. Med., 16, 452, 10.1038/nm.2106

Ostrand-Rosenberg, 2009, Myeloid-derived suppressor cells: linking inflammation and cancer., J. Immunol., 182, 4499, 10.4049/jimmunol.0802740

Bunt, 2006, Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression., J. Immunol., 176, 284, 10.4049/jimmunol.176.1.284

Norris, 2013, Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity., Immunity, 38, 309, 10.1016/j.immuni.2012.10.022

Thông tin
Thông tin xuất bản

Journal of Immunology

Tập 193 Số 11

5461-5469

Thông tin tác giả